Monthly Sales-2023.11
Item Net Revenue 2023.11 777,091 2022.11 653,985 MoM Change 123,106 MoM Change (%) 18.82 2023 1-11 7,505,492 2022 1-11 6,511,162 YoY Change 994,330 YoY Change (%) 15.27 Note
Item Net Revenue 2023.11 777,091 2022.11 653,985 MoM Change 123,106 MoM Change (%) 18.82 2023 1-11 7,505,492 2022 1-11 6,511,162 YoY Change 994,330 YoY Change (%) 15.27 Note
Item Net Revenue 2023.10 679,954 2022.10 633,490 MoM Change 46,464 MoM Change (%) 7.33 2023 1-10 6,728,401 2022 1-10 5,857,177 YoY Change 871,224 YoY Change (%) 14.87 Note
SEQ_NO 1 Date of announcement 2023/11/07 Time of announcement 18:07:38 Subject The Board of Directors approved Q3 2023 consolidated financial statements. Date of events 2023/11/07 To which item it meets paragraph 31 Statement 1.Date of submission to the board of directors or approval by the board of directors:2023/11/07 2.Date of approval by the audit …
The Board of Directors approved Q3 2023 consolidated financial statements. Read More »
Item Net Revenue 2023.09 705,001 2022.09 643,396 MoM Change 61,605 MoM Change (%) 9.57 2023 1-9 6,048,447 2022 1-9 5,223,687 YoY Change 824,760 YoY Change (%) 15.79 Note
2023/04/27 2023/09/21
SEQ_NO 1 Date of announcement 2023/09/20 Time of announcement 17:39:56 Subject The Company is invited to attend an institutional investor conference hosted by President Securities on September 21, 2023. Date of events 2023/09/20 To which item it meets paragraph 12 Statement 1.Date of institutional investor conference:2023/09/21 2.Time of institutional investor conference:16:20 3.Location of institutional …
Item Net Revenue 2023.08 695,296 2022.08 634,672 MoM Change 60,624 MoM Change (%) 9.55 2023 1-8 5,343,446 2022 1-8 4,580,291 YoY Change 763,155 YoY Change (%) 16.66 Note
Item Net Revenue 2023.07 617,997 2022.07 562,980 MoM Change 55,017 MoM Change (%) 9.77 2023 1-7 4,648,150 2022 1-7 3,945,619 YoY Change 702,531 YoY Change (%) 17.81 Note
SEQ_NO 5 Date of announcement 2023/08/08 Time of announcement 18:55:02 Subject Announcement of the resolution by the Board of Directors for capital reduction in cash on behalf of subsidiary Excelsior Healthcare Co., Limited Date of events 2023/08/08 To which item it meets paragraph 11 Statement 1.Date of the board of directors resolution:2023/08/08 2.Reason for …
SEQ_NO 4 Date of announcement 2023/08/08 Time of announcement 18:54:03 Subject Announcement of the resolution by the Board of Directors for capital reduction in cash on behalf of subsidiary Excelsior Medical (HK) Co.,Ltd. Date of events 2023/08/08 To which item it meets paragraph 11 Statement 1.Date of the board of directors resolution: 2023/08/08 2.Reason …